The device, which is delivered transapically, represents an option for very sick patients who previously have had none.

More than 10 million older adults in the U.S. have mild or greater valvular heart disease and the prevalence is expected to grow over the next several decades, according to data from the PREVUE-VALVE ...

Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.

This news is covered by the Medical Dialogues Bureau present at the TCT Conference 2025, being held in San Francisco, ...

Bristol Vet Specialists has launched a new surgical procedure for dogs with mitral valve disease (MVD). The procedure, called ...

Abbott reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR) system.

David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter's Advanced Heart & Vascular Service Line, presented results of the ...

In separate major multicenter trials, two novel valve systems proved effective in severe mitral valve diseases for which there are limited or no options.

Edwards Lifesciences today shared new data demonstrating successful outcomes with its mitral and tricuspid therapies.

Recent findings may be relevant to discussions with patients and their families about the pros and cons of cardiac surgery.

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...

Objective In this study, the impact of regular training on left ventricle morphology in a group of athletes with bicuspid aortic valve (BAV) was evaluated. Design Longitudinal cohort study. A group of ...